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Abstract
Fibrin gels are an ideal natural biological scaffold for tissue engineering because they are biocompatible, 
biodegradable, and have many biological surface markers. However, most research on fi brin gels used commercial 
fi brin kits that could be costly and limited in some areas. In this study, fi brin gels were made by inducing blood 
coagulation by adding a common diagnostic kit to assess the time for blood to clot, called activated partial 
thromboplastin time (aPTT). This induced coagulated plasma (iCoplas)-fi brin gels was evaluated for its ability to 
enhance biological activity of umbilical cord-derived mesenchymal stem cell (UC-MSC), which were cell attachment 
and proliferation. Fibrinogen concentration had infl uence on cell attachment, where only 50% of the cells could 
attach to 77 mg/dl fi brinogen gels whereas 93% cells adhered to 154 mg/dl fi brin gels. There were no signifi cant 
differences in cell proliferation on polysterene culture dish and fi brin gels (p>0.05). These results showed that 
iCoplas-fi brin gels could be used as a fi brin-based scaffold, yielding no signifi cant difference than polysterene-tissue 
culture dish cultures in cell attachment and cell proliferation on 154 mg/dl fi brinogen concentration.
Keywords:  Fibrin gels, mesenchymal stem cells, activated partial thromboplastin time, cell attachment and 
proliferation.
Introduction
Bone defects could be caused by disease, 
degenerative process, or trauma. Treatment 
using cells or materials from the patient and 
implant it to the damaged tissue are called 
autologous treatment. Autologous bone 
grafts are often used to treat bone defects. 
Although this method can produce good 
results, it has drawbacks such as second site 
morbidity, pain, increased risk of surgical 
infection, and limited graft supply. Bone 
substitution method is an alternative method 
that can be used to treat bone defects. 
Physical characteristic of bone substitutes; 
such as porosity, pore size, and surface 
availability, should be considered so that the 
substitute could imitate the condition and 
characteristic of the bone. These characteristic 
is essential for cell attachment, proliferation, 
and differentiation of the cell to generate new 
bone tissues (Castelas et al., 2006).
Tissue engineering is an interdisciplinary 
fi eld that applies the principle of engineering 
and life science,  in the purpose of developing 
a biological substitute that can restore, 
maintain, or improve tissue function or a 
whole organ. Tissue engineering consist into 
three components; cells, scaffold, and signal 
molecules (Ohba et al., 2009). Cells that are 
usually used in tissue engineering are stem 
cells. Stem cells are undifferentiated cells 
that can be differentiated into many other 
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cells. Stem cells also have the ability to self 
renew (Meirelles et al., 2009) making it as an 
advantage for tissue engineering.
Mesenchymal stem cells are adult 
stem cells, commonly found in the bone 
marrow and umbilical cord (Docheva 
et al., 2008). Adult mesenchymal stem 
cells are suitable for clinical use as they 
could attach to plastic, proliferate, and 
differentiate well in vitro, and have suitable 
properties for implantation by having low 
immunogenic and high immunosupressive 
properties (Fosset and Khan, 2011). Umbilical 
cord-derived mesenchymal stem cells are 
much harder to isolate but had a superior 
proliferation potential and more suppressive 
effects on peripheral blood mononuclear 
cell proliferation than bone marrow-derived 
mesenchymal stem cells (Arufe et al., 2011).
Scaffolds are tailored made matrix 
to mimic natural environment for the cell, 
giving it an optimal condition to attach, 
proliferate, and differentiate (Baker and 
Chen, 2012). Fibrin, a natural occurring 
biodegradable matrix, is reported to be 
biocompatible, biodegradable, and has 
many biological surface marker making it 
an ideal natural biological scaffold (Shaikh 
et al., 2008). Several researches on tissue 
engineering have explored the potency of 
commercial fi brin kit to make fi brin-based 
scaffolds. Although benefi ts in effi ciency, 
using commercial fi brin kit could be costly 
and are not always available in some places. 
Activated Partial Thromboplastin Time 
(aPTT) Kit is a coagulation diagnostic kit to 
assess the prothrombin time or the time for 
blood to clot in clinical setting (Korte et al., 
2000). Using aPTT kit to fabricate induced 
coagulated plasma (iCoplas)-fibrin gel 
scaffolds, opens the possibility to use the 
patient’s own blood as autologous scaffolds 
which could decrease the potential risk of 
body reaction (Ye et al., 2000). In this study, 
we observe cell attachment and proliferation 
characteristic of umbilical cord-derived 
mesenchymal stem cells in iCoplas-fibrin 
gels.
Materials and Methods
Ethical Acceptance from the Etchical 
Committee Board
This study had been approved by the 
Institutional Review Board at the Faculty of 
Medicine, Universitas Gadjah Mada (UGM), 
Yogyakarta for collection and study with 
human umbilical cord tissue.
Sample Criteria
Umbilical cord was taken from aterm 
babies (32 until 38 weeks old) born in 
hospitals or clinics that cooperate with this 
research. Inform consent was informed and 
signed by the parents. Samples are stored 
in a sterile 50 ml centrifuge tube containing 
Phosphate Buffer Saline (PBS) (Biobasic, 
Toronto, Canada) supplied with penicillin 
(Gibco, 15140, Invitrogen Corporation, 
NJ, USA) and fungizone (Gibco, 15140, 
Invitrogen Corporation, NJ, USA). Samples 
are processed immediately or stored in 4 oC 
for a maximum 24 hours.
Plasma Col lect ion  and  Fibr inogen 
Concentration Measurement
Whole blood for plasma source were 
obtained from healthy donor, collected in 
citrate vacutainer vacutainer (BD Vacutainer, 
NJ, USA) and processed by centrifugation at 
2000 rpm for 10 minutes at room temperature. 
Fibrinogen concentration in the collected 
plasma citrate was measured by using 
turbidimetry method in Clinical Pathology 
Laboratory, Sardjito Hospital, Yogyakarta.  
Icoplas-fi brin Gel Fabrication
Plasma citrate was diluted with double 
distilled water to obtain 154 mg/dl and 77 
mg/dl fi brinogen concentration. Fibrin gels 
were fabricated by adding 150 μl of plasma 
and 100 μl TriniCLOT aPTT HS (Tcoag, 
Ireland) into a 24-wells plate. To homogenize 
the suspension, the plate was agitated gently 
then incubated in 37 oC for 5 minutes then the 
solution was added by 150μl of warm 0.1 M 
CaCl2 and incubated at room temperature for 
30 minutes. Fabricated fi brin gels were rinsed 
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with phosphate buffered saline and sterilized 
by ultraviolet (UV) radiation for 1 hour.
Mesenchymal Stem Cell Preparation and 
its Characterization
Isolation from umbilical cord by Explant 
Method 
Cells was isolated using the explant 
method, according to Koliakos et al. (2011) 
without any addition in enzymatic reaction. 
Umbilical cord samples were cut into 1 cm3 
pieces and washed with sterilize PBS twice. 
Each explant pieces were cut again into 3 mm3 
explants and washed with Dulbecco’s Modifi ed 
Eagle Media low glucose (DMEM-LG) (Gibco, 
25200, Invitrogen Corporation, Canada). 
Explants were placed into 60 mm culture 
dish and was incubated in room temperature 
for 3 minuets.  The cells were cultured with 
DMEM-LG medium supplemented with 
Fetal Bovine Serum (FBS) 10% (v/v) (FBS Heat 
Inactivated, Caissonlabs, USA), penisilin 
streptomisin 1% (v/v) , dan fungizone 0.5 %. 
Cell culture was incubated in 37 oC, 5% CO2 
with 90% humidity. Culture medium was 
changed every two days and the cells were 
not used past passage 4. Upon reaching 100% 
confulency, cultured cells were trypsinize 
and subcultured.
Characterization of  umbilical cord-derived 
cells by CD45 and Stro-1 expression
Detection of CD45 expression by a. 
immunofl owcytometry
Approximately 105 umbilical cord-
derived cells were centrifuged at 2000 rpm for 
5 minutes. Pellet cells then were added with 
2.5 μl anti-CD45 (BD Bioscience, San Jose, 
CA 95131, USA) and vortex for 2 minutes. 
Cells were then incubated in dark at room 
temperature. Pellet cells were then washed 
with 1 ml of wahing buffer and centrifugated 
at 2 000 rpm for 5 minutes. Pellets cells were 
then resuspended with 100 ml Facsfl ow. Cell 
suspension then transfered to a fl owcytometry 
tube and analyzed using FacsCalibur. 
Detection of STRO-1 expression by b. 
immunocytochemistry (ICC)
Cells with a density of 5x104 cells/
ml was seeded on a cover slip in a 35mm 
TCD and incubated until 70% confl uence. 
Cells on the cover slip were fi xed with cold 
methanol and 0.3% H2O2. Cover slip were 
then washed with PBS and added with 
background snipper and incubated in room 
temperature for 10 minutes. The STRO-1 
primary antibody were added to the cover 
slip and incubated for 10 minutes. Cover 
slip were washed again with PBS and added 
with 100 μl biotinylated universal secondary 
antibody (Novostain Universal Detection Kit 
NCL-RTU, Novocastra Lab LTD, UK) and 
incubated for 10 minutes. Cover slip were 
washed again with PBS and added with 
Betazoid DAB chromogen and incubated 
for 10 minutes. Cover slip were washed 
with aquadest and added 2 μl of counter-
stain MayerHaematoxylin (Dako, Denmark) 
and incubated for 30 seconds. Cover slip 
were then washed with aquadest and dip 
in xylol then alcohol before incubating it in 
room temperature to dry. The dried cover 
slip is then mounted on the object glass and 
observed under the microscope. Cells with 
STRO-1+ will be colored dark brown as for 
negative cells will be blue. 
Cell attachment assay on PS-TCD and fi brin 
gels 
Approximately 104 cells are cultured 
in a 24 well plate with or without fibrin 
gels. Cells were supplemented with growth 
medium and incubated in 37 oC for 1 and 3 
hours. Cells were then trypsinized and cell 
count was done by using hematocytometer. 
Cell proliferation characteristic using MTT 
assay
Approximately 104 cells are cultured 
in a 24 well plate with or without fi brin gels. 
Cells were then incubated in 37 oC for 1, 3, 5, 
and 7 days. Cell proliferation was investigated 
using the MTT assay (refer to Song et al., 2013). 
Medium was changed in every 2 days.
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Osteogenic diferentiation of UC-MSC
Approximately 3x104 cells are cultured in 
a 24 well plate. Cells were then supplemented 
with growth medium and incubated in 37 
oC. On the second day, growth medium was 
changed with osteogenic medium which 
contained DMEM medium, 10% FBS, 150 μg/
ml ascorbic acid, 10 mM β-glycerophosphate 
and10 nM dexamethasone (Silla-Asna et al., 
2007). 
Alizarine Red S staining
Mineralization staining was done 
by using Alizarine Red S staining (Sigma-
aldrich, St. Louise, MO63130, USA). 
Statistical analysis 
All results represent replicates (n=3). 
Statistical analysis was performed using one-
way Analysis of Variance (ANOVA) followed 
by Fisher’s paired Least Signifi cance Difference 
(PLSD) and analyze with Student t-test; a 
p value <0.05 was considered to indicate 
statistical signifi cance.
Results and Discussion
Umbilical cord-derived cells, obtained by 
explant method, express STRO-1 marker and 
did not express the hematopoietic marker, 
CD45
Fibroblast-shaped cells were isolated 
from the umbilical cord using the explant 
method.  Cel l  surface markers  were 
investigated to characterize the isolated 
cells. STRO-1, a proven specifi c mesenchymal 
stem cell marker (Bobis et al., 2006), was 
expressed in cultured cells using the 
immunocytochemistry staining as shown 
by stained brown cells (Figure 1B). CD45, a 
well known hematopoietic marker, was also 
investigated using immunofl owcytometry 
(Docheva et al., 2008). There were 98.24% cells 
that did not express the CD45 marker.
Mesenchymal stem cells are a well 
investigated stem cell due to their unique 
characteristic. However, there are no defi nite 
specifi c marker for the identifi cation of MSC 
(Docheva et al., 2008). To avoid uncertainty, 
in 2006, the International Society for Cellular 
Therapy had proposed minimal criteria 
to define MSC. First, MSC must have the 
ability to attach to plastic in standard culture 
conditions. Second, MSC must express CD73, 
CD90, and CD105 and do not express CD11b, 
CD14, CD19, CD34, CD45, and HLA-DR 
surface markers. Third, MSC must be able to 
differentiate into osteoblast, adipocyte, and 
chondrocyte in vitro (Dominici et al., 2006). 
Fibroblast-like cells were obtained from 
umbilical cord explant. The cells adhered to 
plastic and were expand until 5 passages. 
Immunofl owcytometry using CD45 antibody 
showed 98.24% of the cells did not express 
the CD45 surface marker.
STRO-1 antigen is a well known MSC 
marker (Lin, et al., 2011; Zomorodian and 
Eslaminejad, 2011). Although it still has 
unknown function, STRO-1- cells are not 
capable in forming colony-forming-units-
fi broblast (CFU-F) (Dazzi et al 2006; Kolf et 
al., 2007). Umbilical cord-derived cells form 
CFU-F once they adhered to the plastic 
and proliferate until confluence (Figure 
1C). Immunocytochemistry staining using 
STRO-1 antibody showed the cultured cells 
were positive for STRO-1 marker. 
The ability to differentiate into osteoblast 
was also evaluated by mineralization Alizarine 
Red Staining. Cells culture showed change in 
morphology and increase mineralization 
after 14 days of incubation in osteogenic 
medium  (Figure 1D). Mineralization was 
an indicator for osteoblast maturation and is 
considered as a osteogenic differentiation test 
(Silas-asna et al., 2007). These results indicate 
that the umbilical cord-derived cells, isolated 
by explant culture method, could possibly 
be MSC.
iCoplas-fi brin gel could be degraded after 4 
weeks in basal medium
Icoplas-fibrin gels were successfully 
fabricated using the aPTT kit (Figure 2A). 
Fibrinogen concentration from plasma citrate 
from a single donor was evaluated. Citrate 
plasma from the donor had 154 mg/dl of 
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Figure 1.  Identifi cation of umbilical derived-cells. (A) Immunofl owcytometry using CD45 antibody showed 
98.24% cells are negative; (B) Immunocytochemistry using STRO-1 antibody gave STRO-1+ cells a dark 
brown colour pointed by white arrows. (C) Colony forming unit fi boblast (CFU-F) forms in 3 day cultures 
pointed by dotted arrows; (D) Alizarine staining culture in osteogenic medium showed mineralization by 
formation of red nodules pointed by black arrows. Bars : 50 μm.
Figure 2 . Fibrin gel made by using aPTT Kit. (A) Fibrin gels forms by adding plasma citrate, aPTT HS, 
and CaCl2. (B) Fibrin gel degradation, with 77 mg/dl fi brinogen concentration, visualized using inverted 
microscope after 10 to 14 days of incubation with growth medium. Bars : 50 mm.
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fi brinogen concentration and is used for the 
main concentration to fabricate the fibrin 
gels. In 2008, Ho and coworkers, state that 
fi brinogen concentration of fi brin gels could 
infl uence cell proliferation. To evaluate this 
matter, plasma citrate was diluted with 
aquabidest to 77 mg/dl concentration. 
Fibrin gel was formed after incubation 
of citrate plasma, aPTT HS, and CaCl2 
0.1M. Incubation time for clot formation 
were 7 minutes and 40 seconds and 12 
minutes and 35 seconds for fi brin gel with 
a concentration of 154 mg/dl and 77 mg/
dl, respectively.Fibrin gel degradation assay 
was conducted by incubating fi brin gels in 
growth medium and was observed visually 
under the microscope. The 77 mg/dl fi brin 
gel showed fi brin degradation after 10 to 14 
days of incubation in basal medium as for 
the 154 mg/dl fi brin gel showed no signs of 
degradation after 4 weeks of incubation in 
basal medium (Figure 2).
Higher fibrinogen concentration 
took longer time to degrade. Fibrin gel 
degradation is a natural process, which 
conclude restriction of cross-linking bonds 
and monomer release. In the body, fi brin gels 
or fi brin clots are broken down by plasmin, 
an enzyme produced by the liver, resulting 
in the release of fi brin degradation products 
(FDP) (Cesarman-Maus and Hajjar, 2005; 
Ho et al., 2006). In vitro cell culture fi brin 
degradation could be cause by unstable 
or low forming cross-linking bonds. Low 
Figure 3.  Mesenchymal stem cell characteristic on fi brin gels. (A) Cell attachment assay, cell 
attachment on fi brin gels are infl uenced by fi brinogen concentration; and (B) Proliferation 
assay showed no signifi cant difference in PS and fi brin gel cultures. 
  
 
0
20
40
60
80
100
120
PS-TCD Fibrin 154 mg/dl Fibrin 77 mg/dl
Ce
ll 
at
ta
ch
m
en
t (
%
)
1 hour
3 hour
0
0.5
1
1.5
2
2.5
3
3.5
4
0 1 3 5 7
V
ia
bl
e 
ce
ll 
(1
0^
4)
Incubation Time (days)
PS-TCD
Fibrin 154 
mg/dl
Fibrin 77 
mg/dl
B 
A
I.J. Biotech.
165
Hermantara et al
sequence, R-G-D (arginin-glycine-aspartate 
acid) which could be recognize by specifi c cell 
receptors called integrin (Lee et al., 2004; Ogura 
et al., 2004). This pairing of site specifi c motif 
and integrin will mediate cell attachment and 
the formation of focal adhesion (Frantz et al., 
2010). Lower cell attachment could be cause 
by lower concentration of fi brinogen, limiting 
the availability of site-specific sequences, 
which are signifi cant for cell attachment.
Cell proliferation did not give signifi cant 
difference in PS-TCD and fibrin gel 
scaffolds
Cell proliferation was measured day 
1, 3, 5, and 7 in a 24-well plate. Starting 
density was 5 x103 cell/cm2. Proliferation 
characteristic in PS-TCD and fibrin gels 
gave no signifi cant differences. All cultures 
showed similar patterns in cell proliferation. 
Day 1, there were a decrease of viable cells in 
all cultures. In fi brin gels viable cell number 
decrease until 80.4% and 43.16% in 154 mg/
dl and 77 mg/dl fi brin gels, respectively. 
Huang and co-workers (2010), proposed that 
trypsin induce proteome alteration during 
cell subculture. Furthermore, they found out 
that 36 proteins were expressed differently 
on trypsinized cells, where proteins involve 
in cell metabolism, growth regulation, 
mitochondrial electron transportation, 
and cell adhesion are down-regulated and 
proteins involve in cell apoptosis are up-
regulated. Cells that were transported using 
the trypsinize method would undergo 
apoptosis mechanism resulting in a decrease 
of viable cells.
An increase in cell proliferation was 
observed from day 3 until day 7 for PS-TCD 
and fi brin gel 154 mg/dl cultures. Fibrin gel 
77 mg/dl cultures had increase in viable cell 
until day 5, and decreases on day 7 (Figure 
3).
On day 7, cells cultured on PS-TCD 
showed more viable cells than fibrin gel 
cultures. Variation of the ECM properties 
such as topography, elasticity, and stiffness 
could infl uence cell behavior (Tam et al., 2012). 
concentration of fi brinogen could form fewer 
cross-linking bonds resulting in a shorter 
time of degradation.
Fibrinogen concentration influence cell 
attachment
Cell attachment was measured by cell 
count after 1 and 3 hours of cell seeding into 
the fi brin gel with 154 mg/dl and 77 mg/dl 
fi brinogen concentration. Polysterene tissue 
culture dish (PS-TCD) was used as a control 
as mesenchymal stem cell would attached 
to plastic surface (Ogura et al., 2004). After 1 
hour of seeding, 50%, 43%, and 37.5% cells 
were attached to PS-TCD, fi brin gel 154 mg/
dl, and fibrin gel 77 mg/dl, respectively. 
Cells attached after 3 hours of incubation 
statistically, showed no signifi cant difference 
in PS-TCD, 87.5%, and fi brin gel 154 mg/dl, 
93%. As for fi brin gel 77 mg/dl showed much 
less cell attachment with only 50% cells were 
attached to the scaffold. 
 Mesenchymal stem cells adhered to 
plastic and to fi brin gels. Morphologically 
there are differences in the PS-TCD and fi brin 
gel cultures. In PS-TCD, the cells form a more 
fl attened shaped and in the fi brin gels the 
cells forms a thinner spindle liked shaped. 
Cell attachment onto extracellular matrix 
(ECM) will form focal adhesions bridging the 
ECM and the cytoskeleton of the cell (Tam 
et al., 2012). Focal adhesion is an integrated 
center for cell signaling, mechanosensing, and 
force transduction to mediate cell attachment, 
spreading, and motility in response to ECM 
(Fraley et al., 2010). They consist of multi-
protein complexes (e.g. talin, vinculin, and 
paxillin), and transduce the mechanical 
response to dynamic remodeling of actin 
cytoseleton. Variation in composition and 
physical characteristic of the matrix could 
infl uence cell shape and function due to this 
mechanical feedback from the ECM to cell 
behavior (Tam et al., 2012; Trappmann et al., 
2012).
Cell attachment assay showed fi brinogen 
concentration in fi brin gels could infl uence 
cell attachment. Fibrin possess a site-specifi c 
I.J. Biotech.
166
Hermantara et al
Evans and co-workers (2009) conclude that 
cell growth, proliferation and differentiation 
were all increased as a function on ECM 
stiffness. PS-TCD cultures have higher 
stiffness than fi brin gel cultures, giving it an 
advantage in cell growth and proliferation. 
However, there are more parameters that need 
to be considered for tissue cell culture.
Dimensionally, fibrin gels forms 
a 3-dimensional (3D) structure giving 
it dissimilarity characteristics than the 
2-dimensional (2D) PS-TCD. Baker and 
Chen (2012) proposed that the difference in 
dimensional structure of 3D and 2D could 
effect on soluble gradients, polarity, matrix 
properties, adhesion molecules, and matrix 
stiffness which all then could infl uence on 
cell attachment, growth, proliferation, and 
differentiation.
Conclusion
STRO-1+/CD45- mesenchymal stem cell 
was isolated from the umbilical cord using 
the explant method. These fi broblast-shaped 
cells could attached to plastic and differentiate 
into osteoblast cells. Icoplas-fi brin gels could 
be fabricated using the aPTT kit with citrate 
plasma with fi brin concentration of 154mg/
dl and 77 mg/dl. Cell attachment was 
infl uenced by fi brinogen concentration as for 
higher fi brinogen concentration (154 mg/dl) 
gave no signifi cant difference then PS-TCD 
culture. ECM plays a role in cell proliferation, 
PS-TCD culture with higher stiffness showed 
higher proliferation although did not gave 
signifi cant difference. These results showed 
that iCoplas-fi brin gels could be used as a 
fi brin based scaffold yielding no signifi cant 
difference than PS-TCD cultures in cell 
attachment and cell proliferation on 154 mg/
dl fi brinogen concentration. It is exciting to 
see rather or not iCoplas-fi brin gels share 
differentiation potential than PS-TCD. 
Further research on this matter could lead 
to the possibility of develop an autologous 
treatment for bone engineering. 
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